CTRI/2022/03/041270已完成未知
A Single-Center, Prospective, Open Label Clinical Investigational Study to Validate Accuracy of Pulse Oximeters in Measuring the SpO2 as Compared to Arterial Blood Analysis of SaO2 by CO-Oximetry During Non-Motion Conditions
Choicemmed Technology India Pvt Ltd0 个研究点目标入组 15 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male and female participants aged equal to or more than 18 years and equal to or less than 50 years at the time of consent.
- •2. Participants who can and are willing to provide Informed Consent.
- •3. Participants who understand and are willing to participate in the clinical study and can comply with CIP requirements.
- •4. Participants that are non-smokers.
- •5. Participants having dark pigmentation (Type IV -VI on Fitzpatrick pigmentation scale)
- •6. Presence of both normal upper limbs.
排除标准
- •1. Participants less than 18 years or more than 50 years of age.
- •2.Participants considered as being morbidly obese (defined as BMI more than 39.5).
- •3.Participants with compromised circulation, injury, or physical malformation of fingers, wrist, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study.
- •4.(Note: Certain malformations may still allow to participate if the condition is noted and would not affect the particular sites utilized.)
- •5.Having recent medical tests done that included an injection of dyes, Magnetic resonance imaging (MRI) or Computed Tomography (CT) environment.
- •6.Female participants of childbearing potential having positive UPT at the time of screening.
- •7.Nursing female participants.
- •8.Participants with known respiratory conditions such as: (self-reported/ clinical history)
- •a.Uncontrolled / severe asthma
- •c.Pneumonia / bronchitis
- •d.Shortness of breath / respiratory distress
- •e.Unresolved respiratory or lung surgery with continued indications of health issues
- •f.Emphysema, COPD, lung disease
- •9.Participants with known heart or cardiovascular conditions such as: (self-reported/ clinical history, except for blood pressure and ECG review)
- •a.Hypertension: systolic >140mmHg, Diastolic >90mmHg on 3 consecutive readings (reviewed during health screen).
- •b.Have had cardiovascular surgery
- •c.Chest pain (angina)
- •d.Heart rhythms other than a normal sinus rhythm or with respiratory sinus arrhythmia (reviewed during health screen)
- •e.Previous heart attack
- •f.Blocked artery
- •g.Unexplained shortness of breath
- •h.Congestive heart failure (CHF)
- •i.History of stroke
- •j.Transient ischemic attack
- •k.Carotid artery disease
- •l.Myocardial ischemia
- •m.Myocardial infarction
- •n.Cardiomyopathy
- •10.Participants with following health conditions (self-reported/ clinical history)
- •b.Uncontrolled thyroid disease
- •c.Kidney disease / chronic renal impairment
- •d.History of seizures (except childhood febrile seizures)
- •f.History of unexplained syncope
- •g.Recent history of frequent migraine headaches
- •h.Recent symptomatic head injury (within the last 2 months)
- •i.Cancer / chemotherapy
- •11.Participants with known clotting disorders (self-reported/ clinical history)
- •a.History of bleeding disorders or personal history of prolonged bleeding from injury
- •b.History of blood clots
- •c.Hemophilia
- •d.Current use of blood thinner: prescription or daily use of aspirin
- •12.Participants with severe contact allergies (self-reported/ clinical history) to standard adhesives, latex or other materials found in pulse oximetry sensors.
- •13.Participants having failure of the Perfusion Index Ulnar/Ulnar+Radial Ratio test (Ratio less than 0.4)
- •14.Participants having unwillingness or inability to remove colored nail polish from test digits/ fingers.
- •15.Participants with any other condition, which as per the investigator would jeopardize the outcome of the trial.
- •16.Participants who are not willing to follow study procedures.
研究者
相似试验
Unknown
不适用
Point-of-care device for testing Cardiac Troponin (I and T) for diagnosis of Acute Myocardial Infarction (AMI)CTRI/2021/01/030318Rohit Srivastava53
招募中
不适用
A scientific study to understand the effect of three combined medicine in the Management of Postoperative Symptoms in Patients who Underwent Surgical Treatment for Anorectal DisordersCTRI/2020/11/029298Dr Niranjan Agarwal
已完成
3 期
Clinical Trial to assess efficacy of Parsana Acupressure Therapy plate in Type II Diabetes mellitus, Anxiety, Joint PaiCTRI/2023/09/057271PARSANA Health Centre Pvt Ltd.47
招募中
1 期
A clinical study to assess how safe and effective it is for subjects with hepatocellular carcinoma (HCC) to receive radiation therapy with TheraSphere followed by immunotherapy (durvalumab and tremelimumab treatment)Hepatocellular CarcinomaMedDRA version: 21.1Level: LLTClassification code: 10049010Term: Carcinoma hepatocellular Class: 10029104CTIS2023-508945-41-00Biocompatibles UK Limited107
已完成
3 期
Clinical trial to assess the safety and the efficacy of a new intravenous immune globulin (IGIV3I Grifols10%) in patients with idiopathic (immune) thrombocytopenic purpura.CTRI/2009/091/000860Spectrum Clinical Research Pvt Ltd75